Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver

  • Authors:
    • Asahiro Morishita
    • Teppei Sakamoto
    • Hideki Kobara
    • Tomoko Tadokoro
    • Kyoko Ohura
    • Koji Fujita
    • Joji Tani
    • Hisaaki Miyoshi
    • Hirohito Yoneyama
    • Takashi Himoto
    • Tsutomu Masaki
  • View Affiliations

  • Published online on: November 16, 2015     https://doi.org/10.3892/mco.2015.680
  • Pages: 183-186
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Percutaneous radiofrequency ablation (RFA) enables cauterization of liver cancer in a limited number of sessions without major complications. In contrast to the efficacy of this technique, the size of coagulation necrosis is limited due to increased impedance. D-sorbitol has been used as an irrigating fluid during transurethral resection of the prostate, since it is considered to be a dielectric fluid. In order to determine whether D-sorbitol enhances the effect of RFA, RFA was performed by slowly injecting 3% D-sorbitol near the tip of the RFA needle. The maximum of the total injected volume of D-sorbitol was 20 ml and RFA was terminated if the threshold of impedance was exceeded. RFA and D-sorbitol RFA were performed in 5 different parts of pig livers and dog livers in vivo. The total volumes of coagulation necrosis in the D-sorbitol RFA group were significantly higher compared with those in the RFA group. The total delivered energy in the D-sorbitol RFA group was also higher compared with that in the RFA group, due to the suppression of impedance elevation. No significant complications, such as bleeding or damage, were observed during the D-sorbitol RFA procedure in the in vivo model. In conclusion, RFA combined with D-sorbitol increases the total volume of coagulation necrosis through controlling impedance in the ablated liver and, therefore, D-sorbitol may be useful for the treatment of liver cancers.
View Figures
View References

Related Articles

Journal Cover

February 2016
Volume 4 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Morishita, A., Sakamoto, T., Kobara, H., Tadokoro, T., Ohura, K., Fujita, K. ... Masaki, T. (2016). Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver. Molecular and Clinical Oncology, 4, 183-186. https://doi.org/10.3892/mco.2015.680
MLA
Morishita, A., Sakamoto, T., Kobara, H., Tadokoro, T., Ohura, K., Fujita, K., Tani, J., Miyoshi, H., Yoneyama, H., Himoto, T., Masaki, T."Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver". Molecular and Clinical Oncology 4.2 (2016): 183-186.
Chicago
Morishita, A., Sakamoto, T., Kobara, H., Tadokoro, T., Ohura, K., Fujita, K., Tani, J., Miyoshi, H., Yoneyama, H., Himoto, T., Masaki, T."Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver". Molecular and Clinical Oncology 4, no. 2 (2016): 183-186. https://doi.org/10.3892/mco.2015.680